Comments
Loading...
Inhibikase Therapeutics (NASDAQ:IKT) Stock, Insider Trading Activity
Inhibikase Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Inhibikase Therapeutics Inc Insiders Doing?
At Inhibikase Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 1.97M shares for a total value of $2.70M.
Notable Recent Insider Buys and Sales
- On October 23, 2024, Roberto Bellini, the company's - purchased 1.46M shares for $1.37 each.
- On October 23, 2024, Amit Munshi, the company's - purchased 365K shares for $1.37 each.
- On October 23, 2024, Arvind Kush, the company's - purchased 145K shares for $1.37 each.
Ownership Statistics for Inhibikase Therapeutics Inc
Shares Outstanding
67.193M
Insider Shares Owned
5.529M
Insider Percentage Owned
8.41%
Institutional Shares Held
74.418K
Institutional Percentage Held
0.11%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
IKT Insider Trading News
No news found